Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety

Cefiderocol (Fetroja(®)) is a siderophore cephalosporin and has demonstrated potent activity against extended-spectrum beta-lactamases producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and nonfermenting Gram-negative bacilli, including Pseudomonas aeruginosa, Stenotrophomonas ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Young Ran, Yeo, Suyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374078/
https://www.ncbi.nlm.nih.gov/pubmed/32700154
http://dx.doi.org/10.1007/s40261-020-00955-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374078/
https://www.ncbi.nlm.nih.gov/pubmed/32700154
http://dx.doi.org/10.1007/s40261-020-00955-x

Ejemplares similares